Summary
A new, easy-to-use medical device can help in the diagnosis of brain injuries at the point of care.
Assisting With Initial Diagnosis
The U.S. Food and Drug Administration has given the go-ahead for a new device that can assist medical experts in emergency rooms and on sidelines during their diagnosis of head injuries.
The Ahead 300 is a headset and smartphone that uses 鈥溾�� to analyze head-injured patients. It鈥檚 a quick test that is intended to provide 鈥渁 rapid, objective assessment of the likelihood of the presence of traumatic brain injury (TBI) in patients who present with mild symptoms at the point of care.鈥�
Manufacturer BrainScope this kind of technology is the first of its kind to assess 鈥渢he full spectrum of traumatic brain injury.鈥�
Easy to Use
It鈥檚 a medical tool that has the potential to greatly assist frontline care of head injuries.
鈥淲ith mild TBI as prevalent as it is,鈥� says Geoffrey Ling, MD, COL, USA (Ret.) in a September 26, 2016, BrainScope , 鈥渁n objective easy-to-use point of care device to identify those patients at highest risk of concussion is a critical need.鈥�
The company adds in that release:
BrainScope expects The Ahead 300 to be commercially available in the coming months.
国产外流网Partnership
Development of the product comes in part from grant support by the 国产外流网through the GE/国产外流网Head Health Initiative.
It was also supported by the U.S. Army Medical Research and Materiel Command, with funding from the Defense Medical Research and Development Program.
BrainScope says work on this device and other medical technology has been substantiated by 鈥渃linical evidence emanating from over 20 clinical studies at 55 clinical sites over the past eight years.鈥�